The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Aptar Digital Health, a subsidiary of AptarGroup, Inc., has announced a strategic partnership with Enable Injections to develop a digital companion solution for the enFuse On-Body Delivery System. Under the agreement, Aptar Digital Health has been designated as the preferred digital health partner for Enable's innovative delivery platform. The collaboration aims to enhance the experience for both patients and caregivers by providing comprehensive guidance before, during, and after the drug administration process. This digital integration is designed to improve engagement and ensure the effective delivery of therapies. While the move is a long-term strategic play, it strengthens Aptar's competitive positioning within the digital health and medtech sectors. The partnership underscores a growing industry trend toward combining physical drug delivery systems with sophisticated digital health tools.
Sign in to access this content
Sign In